Salpingo-oophorectomy at the Time of Benign Hysterectomy: A Systematic Review

Evans EC, Elizabeth Casiano Evans, Elizabeth C. Evans, Kristen A. Matteson, Matteson KA, Francisco J. Orejuela, Orejuela FJ, Alperin M, Marianna Alperin, Balk EM, Ethan M. Balk, Sherif A. El‐Nashar, Sherif El-Nashar, Jonathan L. Gleason, Gleason JL, Cara Grimes, Grimes C, Cara L. Grimes, Peter C. Jeppson, Peter Jeppson, Cara Mathews, Thomas M. Wheeler, Wheeler TL, Thomas L. Wheeler, Murphy M, Miles Murphy, Society of Gynecologic Surgeons Systematic Review Group, for the Society of Gynecologic Surgeons Systematic Review Group
Obstetrics and gynecology · 2016 · vol. 128(3) , pp. 476–485 · doi:10.1097/aog.0000000000001592 · PMID:27500347 · PMC5100819 · W2486332150
Systematic review / meta-analysis OA: closed CC0 ⤵ 11 in-corpus citations
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

Bilateral salpingo-oophorectomy eliminates ovarian cancer risk but increases risks of heart disease, cancer mortality, and dementia, particularly in younger women without estrogen therapy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To compare the long-term risks associated with salpingo-oophorectomy with ovarian conservation at the time of benign hysterectomy. DATA SOURCES: MEDLINE, ClinicalTrials.gov, and the Cochrane Central Register of Controlled Trials were searched from inception to January 30, 2015. We included prospective and retrospective comparative studies of women with benign hysterectomy who had either bilateral salpingo-oophorectomy (BSO) or conservation of one or both ovaries. METHODS OF STUDY SELECTION: Reviewers double-screened 5,568 citations and extracted eligible studies into customized forms. Twenty-six comparative studies met inclusion criteria. Studies were assessed for results, quality, and strength of evidence. TABULATION, INTEGRATION, AND RESULTS: Studies were extracted for participant, intervention, comparator, and outcomes data. When compared with hysterectomy with BSO, prevalence of reoperation and ovarian cancer was higher in women with ovarian conservation (ovarian cancer risk of 0.14-0.7% compared with 0.02-0.04% among those with BSO). Hysterectomy with BSO was associated with a lower incidence of breast and total cancer, but no difference in the incidence of cancer mortality was found when compared with ovarian conservation. All-cause mortality was higher in women younger than age 45 years at the time of BSO who were not treated with estrogen replacement therapy (hazard ratio [HR] 1.41, 95% confidence interval [CI] 1.04-1.92). Coronary heart disease (HR 1.26, 95% CI 1.04-1.54) and cardiovascular death were higher among women with BSO (HR 1.84, 95% CI 1.27-2.68), especially women younger than 45 years who were not treated with estrogen. Finally, there was an increase in the prevalence of dementia and Parkinson disease among women with BSO compared with conservation, especially in women younger than age 50 years. Clinical practice guidelines were devised based on these results. CONCLUSION: Bilateral salpingo-oophorectomy offers the advantage of effectively eliminating the risk of ovarian cancer and reoperation but can be detrimental to other aspects of health, especially among women younger than age 45 years.

My notes (saved in your browser only)

MeSH descriptors

Hysterectomy Ovarian Neoplasms Ovariectomy Salpingectomy Age Factors Female Humans Hysterectomy Organ Sparing Treatments Organ Sparing Treatments Outcome and Process Assessment, Health Care Ovarian Neoplasms Ovariectomy Patient Selection Risk Assessment Salpingectomy

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (67)

Cited by (11)

Source provenance

europepmc
last seen: 2026-10-11T09:27:45.537177+00:00
openalex
last seen: 2026-05-13T18:33:16.088889+00:00
pubmed
last seen: 2026-10-08T21:18:17.876363+00:00
License: CC0 · commercial use OK